Literature DB >> 25769207

Accelerating measles elimination and strengthening routine immunization services in Guizhou Province, China, 2003-2009.

Shuyan Zuo1, Lisa Cairns2, Yvan Hutin2, Xiaofeng Liang3, Yibing Tong4, Qing Zhu5, Dayong Zhang5, Lisa A Lee2, Peter Strebel6, Linda Quick7.   

Abstract

BACKGROUND: To develop a successful model for accelerating measles elimination in poor areas of China, we initiated a seven-year project in Guizhou, one of the poorest provinces, with reported highest measles incidence of 360 per million population in 2002.
METHODS: Project strategies consisted of strengthening routine immunization services, enforcement of school entry immunization requirements at kindergarten and school, conducting supplemental measles immunization activities (SIAs), and enhancing measles surveillance. We measured coverage of measles containing vaccines (MCV) by administrative reporting and population-based sample surveys, systematic random sampling surveys, and convenience sampling surveys for routine immunization services, school entry immunization, and SIAs respectively. We measured impact using surveillance based measles incidence.
RESULTS: Routine immunization coverage of the 1st dose of MCV (MCV1) increased from 82% to 93%, while 2nd dose of MCV (MCV2) coverage increased from 78% to 91%. Enforcement of school entry immunization requirements led to an increase in MCV2 coverage from 36% on primary school entry in 2004 to 93% in 2009. Province-wide SIAs achieved coverage greater than 90%. The reported annual incidence of measles dropped from 200 to 300 per million in 2003 to 6 per million in 2009, and sustained at 0.9-2.2 per million in 2010-2013.
CONCLUSIONS: This project found that a package of strategies including periodic SIAs, strengthened routine immunization, and enforcing school entry immunization requirements, was an effective approach toward achieving and sustaining measles elimination in less-developed area of China.
Copyright © 2015. Published by Elsevier Ltd.

Entities:  

Keywords:  Child; China; Epidemiology; Immunization programs; Immunization schedule; Measles; Measles: elimination; Measles: epidemiology; Measles: prevention and control; School entry requirement; Surveillance

Mesh:

Substances:

Year:  2015        PMID: 25769207     DOI: 10.1016/j.vaccine.2015.02.078

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  School-based delivery of routinely recommended vaccines and opportunities to check vaccination status at school, a global summary, 2008-2017.

Authors:  Leora R Feldstein; Garrett Fox; Abigail Shefer; Laura M Conklin; Kirsten Ward
Journal:  Vaccine       Date:  2019-11-01       Impact factor: 3.641

2.  Measles and rubella IgG seroprevalence in persons 6 month-35 years of age, Mongolia, 2016.

Authors:  Francisco Nogareda; Nyamaa Gunregjav; Amarzaya Sarankhuu; Enkhtuya Munkhbat; Enkhbaatar Ichinnorov; Pagbajabyn Nymadawa; Kathleen Wannemuehler; Mick N Mulders; Jose Hagan; Minal K Patel
Journal:  Vaccine       Date:  2020-05-04       Impact factor: 3.641

3.  Safety of measles-containing vaccines in post-marketing surveillance in Anhui, China.

Authors:  Fan-Ya Meng; Yong Sun; Yong-Gang Shen; Hai-Feng Pan; Ji-Hai Tang; Bin-Bing Wang; Chang-Hao Wu; Dong-Qing Ye
Journal:  PLoS One       Date:  2017-02-13       Impact factor: 3.240

4.  Policy and practice of checking vaccination status at school in 2018, a global overview.

Authors:  Katrin Sadigh; Garrett Fox; Nino Khetsuriani; Hongjiang Gao; Stephanie Shendale; Kirsten Ward
Journal:  Vaccine       Date:  2022-03-17       Impact factor: 4.169

5.  Use of a Diagonal Approach to Health System Strengthening and Measles Elimination after a Large Nationwide Outbreak in Mongolia.

Authors:  José E Hagan; Ashley Greiner; Ulzii-Orshikh Luvsansharav; Jason Lake; Christopher Lee; Roberta Pastore; Yoshihiro Takashima; Amarzaya Sarankhuu; Sodbayar Demberelsuren; Rachel Smith; Benjamin Park; James L Goodson
Journal:  Emerg Infect Dis       Date:  2017-12       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.